SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-006192
Filing Date
2018-03-19
Accepted
2018-03-19 16:07:47
Documents
3
Period of Report
2018-03-19
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K life-8k_20180319.htm 8-K 34135
2 EX-99.1 life-ex991_8.htm EX-99.1 194037
3 GRAPHIC g2018031805344936416923.jpg GRAPHIC 17344
  Complete submission text file 0001564590-18-006192.txt   253518
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37378 | Film No.: 18698809
SIC: 2836 Biological Products, (No Diagnostic Substances)